Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Abbott purchases additional La Jolla stock

Dec. 1, 1998

OraVax files IND for colitis vaccine

Nov. 30, 1998

North American Vaccine continues product launch of Certiva in U.S.

Nov. 26, 1998

Positive clinical data supports Siga's unique vaccine delivery system

Nov. 25, 1998

Chiron reports phase II results of novel Meningococcus C vaccine trial

Nov. 24, 1998

Thalidomide analogue CC-3052 is more active, less toxic than parent drug

Nov. 23, 1998

Phase II data demonstrate efficacy of Avant's rotavirus vaccine

Nov. 23, 1998

SangCya launched in U.S. less than three weeks following approval

Nov. 20, 1998

Intellivax presents promising phase I data for intranasal vaccine for shigellosis

Nov. 20, 1998

New LYMErix study results point to faster immunization

Nov. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...